MATTHEW RADEL: Open Payments
NPI 1649621624 · ORCHARD PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$623 in 32 payments from 11 companies in 2025. Trend: 2023 $545 · 2024 $551 · 2025 $623
Food & beverage: $623
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $179 |
| Sumitomo Pharma America, Inc. | 6 | $111 |
| ABBVIE INC. | 3 | $70 |
| Astellas Pharma US Inc | 4 | $66 |
| Ferring Pharmaceuticals Inc. | 3 | $60 |
| Procept Biorobotics Corporation | 1 | $29 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $26 |
| Endo USA, Inc. | 1 | $24 |
| Telix Pharmaceuticals | 1 | $23 |
| CIVCO Medical Instruments | 1 | $19 |
Products named: XTANDI, GEMTESA, ADSTILADRIN, BOTOX, AQUABEAM ROBOTIC SYSTEM, LUPRON DEPOT, PYLARIFY, AVEED.
Industry payments across NY — which companies pay providers there.
